By Louis Navellierof
NEW YORK ( TheStreet) -- A typical "penny stock," believe it or not, can trade for as much as $5 a share. The idea behind penny stocks is the same, however, whether the investment is worth 3 cents or $3.03 -- a very small-cap equity or microcap stock with the ability to break out and post big gains.
When I screen for penny stocks, I always omit companies that are illiquid, trading for only a few pennies or listed on the pink sheets. These penny stocks are just too risky to make sense. However, that doesn't mean investors can't find a number of bargain breakouts by combing through cheap stocks.
Here are eight examples of breakout penny stocks in the health care sector. All it takes is one big drug approval, a buyout from big pharma or a plump contract from a major provider to send shares of penny stocks like these soaring.
Cardica (CRDC)Cardica (CRDC - Get Report) designs, manufactures and markets products used by cardiac surgeons. These products are frequently used when performing coronary bypass surgery. Cardica also makes endoscopic microcutters which are used in various other surgeries. This penny stock has boasted an impressive gain of 82.8% since January. In early August, Cardica reported total product sales of $1 million for its fiscal fourth quarter ending June 30. Its stock price of $2.14 is down slightly from its 52-week high of $2.85; however Cardica is still a good bargain buy at this time.
Pro-Dex (PDEX)Based in Santa Ana, Calif., Pro-Dex (PDEX - Get Report) designs, develops and manufactures rotary drive systems for the medical device and dental industries. These rotary systems are also used in cranial, spinal, arthroscopic and orthopedic surgery. This penny stock has climbed 46.5% since January, or 71 cents a share. In its last income statement, PDEX reported quarterly revenue growth of 33.7% year over year, along with a net profit margin of 2.82%. Investors can buy into Pro-Dex stock at $2.22 per share.
CAS Medical Systems (CASM)Medical-technology company CAS Medical Systems (CASM - Get Report) develops manufactures and markets non invasive patient monitoring products. The company's products are divided into the following segments: critical care monitoring, blood pressure measurement technology and bedside monitoring. While this penny stock is up just 4.7% year-to-date, it is still riding high from its 52-week change of 43.2%. Its stock price of $2.22 is not far off from its 52-week high of $2.51, which is an encouraging sign for potential investors.
TearLab (TEAR)TearLab (TEAR - Get Report) is known by many by its former name of OccuLogix. Based in San Diego, the health care company is known for its tear testing platform which allows eye doctors to test for highly sensitive and specific biomarkers. Since March 1, the stock has climbed an incredible 162%. The huge spike in stock price occurred when OccuLogix announced that investors had agreed to buy 1.5 million shares of the company's common stock for $3.22 per unit. The purchase cost investors approximately $5 million and sent TearLab's stock surging. Since the purchase, the stock has leveled off, however at $2.63 a share, this penny stock is still worth buying.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.